Viltolarsen
NS-065/NCNP-01-302
Phase 3 small_molecule active
Quick answer
Viltolarsen for Duchenne Muscular Dystrophy (DMD) is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Duchenne Muscular Dystrophy (DMD)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active